scispace - formally typeset
G

Germán Bou

Researcher at University of A Coruña

Publications -  337
Citations -  20952

Germán Bou is an academic researcher from University of A Coruña. The author has contributed to research in topics: Acinetobacter baumannii & Medicine. The author has an hindex of 58, co-authored 308 publications receiving 17715 citations. Previous affiliations of Germán Bou include National University of Rosario & Autonomous University of Madrid.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.

Marina Pollán, +95 more
- 22 Aug 2020 - 
TL;DR: In this paper, a nationwide population-based study aims to estimate the seroprevalence of SARS-CoV-2 infection in Spain at national and regional level.
Journal ArticleDOI

Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?

TL;DR: This review considers how bacterial virulence and fitness are affected by antibiotic resistance and also how the relationship between virulent and resistance is affected by different genetic mechanisms and by the most prevalent global responses.
Journal ArticleDOI

Complete Dna-Sequence Of Yeast Chromosome-Xi

Bernard Dujon, +112 more
- 02 Jun 1994 - 
TL;DR: The complete DNA sequence of the yeast Saccharomyces cerevisiae chromosome XI has been determined, and the 666,448-base-pair sequence has revealed general chromosome patterns.
Journal ArticleDOI

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez-Gutiérrez, +93 more
TL;DR: Patients with BSIs due to CPE should receive active therapy as soon as they are diagnosed, and monotherapy should be considered for those in the low-mortality-score stratum.